1. Home
  2. SOBR vs QNRX Comparison

SOBR vs QNRX Comparison

Compare SOBR & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOBR
  • QNRX
  • Stock Information
  • Founded
  • SOBR 2004
  • QNRX 2018
  • Country
  • SOBR United States
  • QNRX United States
  • Employees
  • SOBR N/A
  • QNRX 3
  • Industry
  • SOBR Newspapers/Magazines
  • QNRX Medical/Dental Instruments
  • Sector
  • SOBR Consumer Discretionary
  • QNRX Health Care
  • Exchange
  • SOBR Nasdaq
  • QNRX Nasdaq
  • Market Cap
  • SOBR 4.9M
  • QNRX 4.8M
  • IPO Year
  • SOBR N/A
  • QNRX N/A
  • Fundamental
  • Price
  • SOBR $3.24
  • QNRX $8.20
  • Analyst Decision
  • SOBR
  • QNRX
  • Analyst Count
  • SOBR 0
  • QNRX 0
  • Target Price
  • SOBR N/A
  • QNRX N/A
  • AVG Volume (30 Days)
  • SOBR 14.7K
  • QNRX 107.3K
  • Earning Date
  • SOBR 11-13-2025
  • QNRX 11-06-2025
  • Dividend Yield
  • SOBR N/A
  • QNRX N/A
  • EPS Growth
  • SOBR N/A
  • QNRX N/A
  • EPS
  • SOBR N/A
  • QNRX N/A
  • Revenue
  • SOBR $301,400.00
  • QNRX N/A
  • Revenue This Year
  • SOBR N/A
  • QNRX N/A
  • Revenue Next Year
  • SOBR N/A
  • QNRX N/A
  • P/E Ratio
  • SOBR N/A
  • QNRX N/A
  • Revenue Growth
  • SOBR 73.21
  • QNRX N/A
  • 52 Week Low
  • SOBR $2.41
  • QNRX $5.01
  • 52 Week High
  • SOBR $193.50
  • QNRX $54.95
  • Technical
  • Relative Strength Index (RSI)
  • SOBR 44.82
  • QNRX 56.75
  • Support Level
  • SOBR $3.08
  • QNRX $7.35
  • Resistance Level
  • SOBR $3.31
  • QNRX $10.00
  • Average True Range (ATR)
  • SOBR 0.20
  • QNRX 0.43
  • MACD
  • SOBR 0.01
  • QNRX 0.11
  • Stochastic Oscillator
  • SOBR 51.18
  • QNRX 25.85

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: